Generic EpiPen alternative to hit the market in early 2019

https://www.cbsnews.com/news/generic-epipen-drug-maker-sandoz-to-sell-alternative-symjepi/

CBS/AP December 7, 2018, 4:11 PM

Generic drugmaker Sandoz announced plans Thursday to start selling an alternative to the EpiPen in the U.S. early next year. The name-brand injector has come under fire for rising prices and supply problems.

The EpiPen injector is used to halt life-threatening allergic reactions to insect bites, nuts and other foods. Brand-name EpiPen, which dominates the market, has been in short supply since spring because of production problems.

Sandoz will sell prefilled syringes with the same medicine, the hormone epinephrine, under the name Symjepi. The price will be $250 for two, without insurance.

Two generic versions of EpiPen are sold in the U.S. for $300 a pair, including one from EpiPen seller Mylan. The company started selling its own generic after it was blasted for repeated hikes that pushed up its list price from $94 to $608 for a pair of brand-name EpiPens.

•••••